Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.39 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.39 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27200569 | 1.00 | GPR84 (0.43) | GPR84FFAR1FFAR4FAAHLCK | |
| SCHEMBL14915950 | 1.00 | GPR84 (0.43) | GPR84FFAR1FFAR4FAAHLCK | |
| SCHEMBL29205060 | 0.90 | GPR84 (0.42) | GPR84FFAR1FAAHLCKPPARD | |
| SCHEMBL29205061 | 0.90 | GPR84 (0.42) | GPR84FFAR1FAAHLCKPPARD | |
| SCHEMBL29205062 | 0.90 | GPR84 (0.42) | GPR84FFAR1FAAHLCKPPARD | |
| SCHEMBL7920334 | 0.80 | MEN1 (0.46) | GPR84FFAR1FFAR4FAAHMMP3 | |
| SCHEMBL21111560 | 0.78 | MMP3 (0.45) | GPR84FFAR1FFAR4FAAHACE2 | |
| SCHEMBL2896967 | 0.78 | MAPT (0.47) | GPR84FFAR1FFAR4FAAHMMP3 | |
| SCHEMBL14655966 | 0.75 | FFAR4 (0.45) | GPR84FFAR1FFAR4FAAHACE2 | |
| SCHEMBL2374648 | 0.75 | GPR84 (0.42) | GPR84FFAR1FFAR4FAAHLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2827842-A1 | CYCLODEXTRIN-BASED MICROEMULSIONS, AND DERMATOLOGICAL USES THEREOF | Precision Dermatology, Inc. (US) | 2015-01-28 | — | — | EP | claimed |
| WO-2013142251-A1 | CYCLODEXTRIN-BASED MICROEMULSIONS, AND DERMATOLOGICAL USES THEREOF | PRECISION DERMATOLOGY, INC. (US) | 2013-09-26 | — | — | WO | claimed |
| WO-2013142247-A1 | CYCLODEXTRIN-BASED MICROEMULSIONS, AND DERMATOLOGICAL USES THEREOF | PRECISION DERMATOLOGY, INC. (US) | 2013-09-26 | — | — | WO | claimed |
| WO-2013142249-A1 | CYCLODEXTRIN-BASED MICROEMULSIONS, AND DERMATOLOGICAL USES THEREOF | PRECISION DERMATOLOGY, INC. (US) | 2013-09-26 | — | — | WO | claimed |
| EP-2579851-A2 | HIGH OIL-CONTENT EMOLLIENT AEROSOL FOAM COMPOSITIONS | Precision Dermatology, Inc. (US) | 2013-04-17 | — | — | EP | claimed |
| EP-2563336-A2 | AEROSOL FOAMS COMPRISING CLINDAMYCIN PHOSPHATE | Precision Dermatology, Inc. (US) | 2013-03-06 | — | — | EP | claimed |
| EP-2538920-A1 | EMOLLIENT FOAMS FOR TREATMENT OF DERMATOSES | Precision Dermatology, Inc. (US) | 2013-01-02 | — | — | EP | claimed |
| US-20110305643-A1 | High Oil-Content Emollient Aerosol Foam Compositions | PRECISION DERMATOLOGY, INC. (US) | 2011-12-15 | — | — | US | claimed |
| US-20110236321-A1 | Aerosol Foams Comprising Clindamycin Phosphate | PRECISION DERMATOLOGY, INC. (US) | 2011-09-29 | — | — | US | claimed |
| WO-2011119585-A2 | AEROSOL FOAMS COMPRISING CLINDAMYCIN PHOSPHATE | PRECISION DERMATOLOGY, INC. (US) | 2011-09-29 | — | — | WO | claimed |
| WO-2011115700-A2 | EMOLLIENT FOAMS FOR TREATMENT OF SEBORRHEIC DERMATITIS | PRECISION DERMATOLOGY, INC. (US) | 2011-09-22 | — | — | WO | claimed |
| US-20110229417-A1 | Emollient Foams for Treatment of Seborrheic Dermatitis | SALIX PHARMACEUTICALS, LTD. | 2011-09-22 | — | — | US | claimed |
| WO-2011106026-A1 | EMOLLIENT FOAMS FOR TREATMENT OF DERMATOSES | PRECISION DERMATOLOGY, INC. (US) | 2011-09-01 | — | — | WO | claimed |
| US-12414962-B2 | Method for treating C. acnes bacteria-associated diseases | ELIGO BIOSCIENCE (FR) | 2025-09-16 | — | — | US | disclosed |
| US-20250195406-A1 | COMPOSITIONS AND METHODS OF IMPROVING THE SKIN MICROBIOME | SEED HEALTH INC. | 2025-06-19 | — | — | US | disclosed |
| EP-4509174-A2 | COMPOSITIONS AND METHODS FOR PROMOTING SKIN HEALTH | The Regents of the University of California (US) | 2025-02-19 | — | — | EP | disclosed |
| US-20110236321-A1 | Aerosol Foams Comprising Clindamycin Phosphate | PRECISION DERMATOLOGY, INC. (US) | 2011-09-29 | — | — | US | disclosed |
| US-20110229417-A1 | Emollient Foams for Treatment of Seborrheic Dermatitis | SALIX PHARMACEUTICALS, LTD. | 2011-09-22 | — | — | US | disclosed |
| WO-2011115700-A2 | EMOLLIENT FOAMS FOR TREATMENT OF SEBORRHEIC DERMATITIS | PRECISION DERMATOLOGY, INC. (US) | 2011-09-22 | — | — | WO | disclosed |
| WO-2011106026-A1 | EMOLLIENT FOAMS FOR TREATMENT OF DERMATOSES | PRECISION DERMATOLOGY, INC. (US) | 2011-09-01 | — | — | WO | disclosed |